Elanco Animal Health INC Form 4 insider transactions

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 7.8029 deferred stock units as part of a pre-arranged plan.

Rajeev A. Modi, Elanco's EVP, acquired 60.2735 deferred stock units on January 9, 2026, increasing his direct beneficial ownership.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 8.1121 deferred stock units under a pre-arranged plan.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 117.9906 deferred stock units on January 9, 2026, increasing his beneficial ownership.

Elanco Animal Health Director Kapila K. Anand deferred cash retainer fees into 381.1312 Deferred Stock Units, increasing her beneficial ownership to 8,894.7414 units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 122.5327 deferred stock units, increasing his beneficial ownership to 18,727.5311 units.

Elanco Animal Health Executive Vice President Rajeev A. Modi acquired 62.5938 deferred stock units on December 26, 2025.

Elanco Animal Health Inc. Director R. David Hoover reported a gift of 60,000 shares of common stock to a charitable trust, executed under a Rule 10b5-1 plan.

Elanco Animal Health Inc. Director Lawrence Kurzius purchased 10,000 shares of common stock at $21.30 per share.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired 66.4453 deferred stock units at a price of $21.29 per unit.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 130.0723 deferred stock units, increasing his beneficial ownership in the company.

Elanco Animal Health Inc.'s Executive Vice President, Rajeev A. Modi, purchased 4,500 shares of common stock at $21.33 per share, increasing his direct beneficial ownership to 123,082 shares.

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, purchased 6,950 shares of common stock for approximately $150,596 under a Rule 10b5-1 plan.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, purchased 22,000 shares of common stock for approximately $478,495 on December 11, 2025.

Elanco Animal Health Director Stacey Ma was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 119.0047 deferred stock units as part of an executive compensation plan.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 60.7916 deferred stock units at a price of $23.27 per unit.

Elanco Animal Health Inc. director Kapila K. Anand was granted 10,314 deferred stock units as part of an annual equity award.

Elanco Animal Health Director Denise Scots-Knight was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. director Kirk P. McDonald was granted 10,314 deferred stock units as part of an annual equity award for non-employee board members.

Elanco Animal Health Inc. Director Lawrence Kurzius was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. director Deborah Turner Kochevar was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Inc. Director R. David Hoover was granted 10,314 shares of common stock as an annual equity award.

Elanco Animal Health Inc. Director Paul Herendeen was granted 10,314 deferred stock units as an annual equity award.

Elanco Animal Health Director Art A. Garcia was granted 10,314 deferred stock units as part of his annual equity award.

Elanco Animal Health Inc. Director Michael J. Harrington was granted 10,314 deferred stock units as an annual equity award.

Elanco EVP Rajeev A. Modi reported acquiring 67.0754 deferred stock units at $21.09, increasing his DSU holdings to 7,230.2452.

Elanco CEO Jeffrey N. Simmons acquired 131.3058 deferred stock units at $21.09 and now directly holds 18,355.9214 DSUs under the company’s Executive Deferral and Stock Match Plan.

Elanco Animal Health Inc's President and CEO, Jeffrey N. Simmons, acquired 125.0221 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health's EVP, Rajeev A. Modi, reported the acquisition of 63.8655 deferred stock units, effective October 31, 2025, under a Rule 10b5-1 plan.